FIELD: chemistry.
SUBSTANCE: invention relates to pyridone amide compounds of formula I and I'
where, independently for each case: G is
or ;
X is a bond or C1-C6 alkyl, wherein said C1-C6 alkyl is substituted with 0-6 halogen atoms, where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-; Rx is absent, is H or C3-C8 cycloaliphatic group, where up to two non-neighbouring CH2 units of the C3-C8 cycloaliphatic group can be substituted with -O- and said C3-C8 the cycloaliphatic group is substituted with 0-3 substituents selected from halogen and C1-C4 alkyl; R1 is H, halogen, CN or C1-C6 alkyl, where said C1-C6 alkyl is substituted with 0-6 halogen atoms and where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-; R2 is H, halogen, CN or C1-C6 alkyl, wherein said C1-C6 alkyl is substituted with 0-6 halogen atoms, where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-; R3 is H, halogen, CN or C1-C6 alkyl, wherein said C1-C6 alkyl is substituted with 0-6 halogen atoms, where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-; R4 is H, halogen, CN or C1-C6 alkyl, where said C1-C6 alkyl is substituted with 0-6 halogen atoms, where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-; R5 is H, halogen, CN or -X-Rx; R5’ is H, halogen, CN or -X-Rx; R6 is H, halogen, CN or -X-Rx; R6’ is H, halogen, CN or -X-Rx; R7 is H, halogen, CN or -X-Rx; R8 is a halogen or C1-C6 alkyl, where said C1-C6 alkyl is substituted with 0-6 halogen atoms, where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-; p is an integer from 0 to 3, inclusively; and R9 is H or C1-C6 alkyl, where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-.
EFFECT: invention relates to pharmaceutically acceptable salts used as inhibitors of sodium channels.
48 cl, 4 tbl, 30 ex
Title | Year | Author | Number |
---|---|---|---|
PYRIDONAMIDES AS SODIUM CHANNELS MODULATORS | 2014 |
|
RU2808424C2 |
AMIDES AS MODULATORS OF SODIUM CHANNELS | 2014 |
|
RU2658920C2 |
PRODRUGS OF PYRIDONAMIDES USED AS MODULATORS OF SODIUM CHANNELS | 2014 |
|
RU2692766C1 |
PYRIDONAMIDE PRODRUGS USED AS SODIUM CHANNELS MODULATORS | 2014 |
|
RU2811402C2 |
SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | 2012 |
|
RU2668952C2 |
AMIDES OF CONDENSED PIPERIDINE AS MODULATORS OF ION CHANNELS | 2014 |
|
RU2741810C2 |
2-ARYLIMIDAZO[1,2-b]PYRIDAZINE,2-PHENYLIMIDAZO[1,2-a]PYRIDINE AND 2-PHENYLIMIDAZO[1,2-a]PYRAZINE DERIVATIVES | 2011 |
|
RU2598385C2 |
2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2661197C2 |
NOVEL 707 COMPOUNDS AND USE THEREOF | 2008 |
|
RU2472781C2 |
Authors
Dates
2018-07-25—Published
2014-01-29—Filed